Anthony Saleh, PhD, is a serial biotech entrepreneur and the CEO of miRecule, Inc. Leveraging his doctorate from Johns Hopkins and over 15 years of experience in RNA research from institutions like the NIH, he leads the development of precision RNA therapeutics for cancer and rare genetic diseases. He is the lead inventor on his companys discovery platform.
Anthonys professional mission is deeply intertwined with his personal life. After losing his grandparents to cancer, he pursued a career in therapeutic design. His focus on facioscaphumercal muscular dystrophy (FSHD) is driven by the fact that the genetic disease runs in his family, and he himself has been diagnosed with the disorder.
His company is developing an RNA therapy for the rare muscular disease that personally affects him and his family.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.